Various hexahydropyrazino [1,2-b]isoquinolines were synthesised as simplified saframycin analogues. Construction of this core proceeded through a tetrahydroisoquinoline synthesis followed by acylation/alkylation of the tetrahydroisoquinoline nitrogen and subsequent ring closure using various aliphatic and aromatic amines. The resulting piperazinones were reacted with LiAlH 4 or LiAlH(OEt) 3 to synthesise further analogues.
Saframycins 1, isolated from Streptomyces lavendulae, belong to a family of microbial fermentation products with a remarkable antiproliferative activity. The most active derivative is saframycin A (1a), a bisquinone alkaloid bearing an α-aminonitrile function. 2 The mode of activity is connected to the iminium ions generated from this α-aminonitrile unit thus covalently modifying DNA. Quinoid alkaloids with antiproliferative activity such as the ecteinascidines, 3 isolated from the marine tunicate Ecteinascidia turbinata, have raised new interest towards the synthesis of saframycin analogues.
Trabectedin (2; also known as ecteinascidin 743 or is an antitumor drug approved for the treatment of advanced soft-tissue sarcoma. It is sold by Zeltia and Johnson & Johnson under the brand name Yondelis for the treatment of advanced soft-tissue sarcoma. Currently, simplified analogues such as phthalascidin (3) are known, bearing a similar activity 4 (Figure 1 ). All these compounds can be considered as dimers of structurally less complex tetrahydroisoquinoline subunits. Synthesis of this kind of simplified analogues has received little attention as most work focusses on total synthesis. 5 Nevertheless, related piperazinones and diketopiperazines have been prepared before 6 and pyrazino [1,2b] isoquinolines have been examined for cytotoxicity. 7 Therefore, the synthesis of quinone-type derivatives under their hydroquinone methyl ether form was envisaged. We recently reported the synthesis of functionalised diketopiperazines as cyclotryprostatin and tryprostatin analogues. 8 It was subsequently envisaged to apply this methodlogy to the synthesis of simplified saframycin analogues. In initial studies, ethyl N-(diphenylmethylene)glycinate (4) failed to react with bromomethyl derivatives 5 (Na or KHMDS, -78°C or 0°C 9 ) but complete conversion was obtained upon reaction with KOH in H 2 O-CH 2 Cl 2 using Bu 4 NHSO 4 as a phase-transfer catalyst. Tetrahydroisoquinoline 7a was synthesised by means of a Pictet-Spengler reaction starting from 1-bromomethyl-2,5-dimethoxy-3,4-dimethylbenzene (5a) 10a via intermediate amine 6 in a yield of 76% over two steps. Tetrahydroisoquinolines 7b-d were synthesised by reaction of bis(bromomethyl)benzene derivatives 5b-d 10b-e with ethyl N-(diphenylmethylene)glycinate (4) under basic conditions followed by acid-induced ring closure in 60-80% yields. 11 Next, the nitrogen atom was acylated with chloroacetyl chloride to afford N-chloroacetyl tetrahydroisoquinolines 8 in 50-70% yield 12 or alkylated with 1,2-dibromoethane to yield N-(2-bromoethyl)tetrahydroisoquinolines 9 in 70-94% yield 13 (Scheme 1). Finally, N-chloroacetyl tetrahydroisoquinolines 8 were reacted with various primary amines in EtOH towards diketopiperazines 10 in good to excellent yields (Table 1 ). 14 Starting from N-(2-bromoethyl)tetrahydroisoquinolines 9, a range of piperazinones 11 was synthesised in high, albeit somewhat lower yields than diketopiperazines 10 ( Table 2) . 15 The lactam function of piperazinones 11 was further reduced to create additional saframycin analogues. Reaction with LiAlH 4 resulted in complete reduction of the lactam moiety leading to piperazines 14 in 70-80% yield. 16 Reaction with the less reactive LiAlH(OEt) 3 gave the hemiaminals, which were further converted into aminonitriles 13 with potassium cyanide and acetic acid. 17 One piperazinone was demethylated with boron(III) bromide followed by oxidation with HNO 3 to yield quinone 12 (Scheme 2). 18 Scheme 1 Reagents and conditions: a) 30% aq KOH, Bu 4 NHSO 4 (1 equiv), CH 2 Cl 2 , r.t., 12 h; b) HCl (2 M) THF, r.t., 15 h; c) 37% HCHO in H 2 O (2 equiv), TFA (2 equiv), CH 2 Cl 2 , Δ, 2 h; d) 30% aq KOH, Bu 4 NHSO 4 (1 equiv), CH 2 Cl 2 , r.t., 30 min; e) HCl (2 M) THF, r.t., 30 min; f) ClCH 2 COCl (1.5 equiv), Et 3 N (1.5 equiv), CH 2 Cl 2 , r.t., 2 h; g) BrCH 2 CH 2 Br (20 equiv), K 2 CO 3 (1 equiv), neat, 80 °C, 24 h. 
In summary, a library of hexahydropyrazino [1,2-b] isoquinolines has been synthesised as representative simplified saframycin analogues. Both piperazinones and diketopiperazines were synthesised. The piperazinones were further reacted with LiAlH 4 to obtain piperazines or LiAlH(OEt) 3 and KCN to insert an α-aminonitrile function. 2-(2-Chloroacetyl)-5,8-dimethoxy-6,7-dimethyl-1,2,3,4- 2-(2-Bromoethyl)-5,8-dimethoxy-1,2,3,4 (1 H, d, J = 16.8 Hz, (2 H, m, OCH 2 ), 6.60 (1 H, d, J = 9.1 Hz, 6.62 (1 H, d, J = 9.1 Hz, . 13 (14) 7,10-Dimethoxy-8,9-dimethyl-2-propyl-2,3,11,11atetrahydro-6H-pyrazino[1,2-b] isoquinoline-1,4-dione (10a) A mixture of ethyl 2-(2-chloroacetyl)-5, 8-dimethoxy-6,7dimethyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylate (8a, 184 .5 mg, 0.5 mmol) and n-propylamine (132.5 mg, 2.5 mmol) in anhydrous EtOH (10 mL 15) 7,10-Dimethoxy-2-propyl-3,4,11,11a-tetrahydro-2H,6Hpyrazino[1,2-b] isoquinolin-1-one (11b) A mixture of ethyl 2-(2-bromoethyl)-5,8-dimethoxy-1,2,3,4tetrahydroisoquinoline-3-carboxylate (9b) (186 mg, 0.5 mmol) and n-propylamine (132.5 mg, 2.5 mmol) in anhydrous EtOH (10 mL) was stirred for 24 h at r.t. Then, the mixture was poured onto H 2 O and exhaustively extracted with EtOAc. The combined organic phases were washed, dried (MgSO 4 ), filtered, and evaporated in vacuo. Purification by chromatography on silica (hexane-EtOAc) gave pure 7,10-dimethoxy-2-propyl-3,4,11,11a-tetrahydro-2H,6H-pyrazino [1,2-b] isoquinolin-1-one (11b, 120 mg, 79% 
